![conference banner](/images/conference-banner.jpeg)
Abstract
Background: In view of the need of discovering new antifungal agents, the synthesis of compounds comprising new structural scaffolds is an important approach, since they may act by new mechanisms of action and overcome resistance issues.
Objective: Synthesis of new 1,2-benzisoxazolin-3-ones inspired in eugenol and ebselen as new antifungal agents against Candida spp.
Methods: A series of 1,2-benzisoxazolin-3-ones, based on eugenol and analogs, was synthesized by the cyclization of the respective hydroxamic acids under Mitsunobu conditions. IR, NMR, and MS spectroscopies characterized the synthesized compounds. The final products were screened for their antifungal activity against five Candida spp., using microdilution assays and cytotoxicity against peripheral blood mononuclear cells by the MTT method.
Results: The products were obtained in good yields and the results showed that most of the synthesized compounds were better antifungal agents than eugenol against the Candida species evaluated and that the derivative IVd (IC50 53 μmol L-1) showed activity comparable to fluconazole against C. glabrata. Moreover, IVd showed the best selectivity profile among the synthesized new compounds.
Conclusion: A new 1,2-benzisoxazolin-3-one (IVd) was obtained as a promising candidate for the development of new antifungal agents based on a new chemical scaffold.
Keywords: 1, 2-benzisoxazolin-3-ones, eugenol, molecular hybridization, Candida spp., antifungals, MTT method.
Current Bioactive Compounds
Title:A New 1,2-Benzisoxazolin-3-one Synthetized from Eugenol Shows Anti- Candida Spp. Activity, Specially Against Opportunistic Candida Glabrata
Volume: 17 Issue: 5
Author(s): Antonio M. Fregnan, Antonio A. Fernandes Júnior, Dalila J. Alvarenga, Josidel C. Oliver, Naiara C. Silva, Luiz F.L. Coelho, Amanda L. Tranches Dias, Danielle F. Dias, Thiago B. de Souza and Diogo T. Carvalho*
Affiliation:
- Departamento de Alimentos e Medicamentos, Faculdade de Ciencias Farmaceuticas, Universidade Federal de Alfenas, Alfenas,Brazil
Keywords: 1, 2-benzisoxazolin-3-ones, eugenol, molecular hybridization, Candida spp., antifungals, MTT method.
Abstract:
Background: In view of the need of discovering new antifungal agents, the synthesis of compounds comprising new structural scaffolds is an important approach, since they may act by new mechanisms of action and overcome resistance issues.
Objective: Synthesis of new 1,2-benzisoxazolin-3-ones inspired in eugenol and ebselen as new antifungal agents against Candida spp.
Methods: A series of 1,2-benzisoxazolin-3-ones, based on eugenol and analogs, was synthesized by the cyclization of the respective hydroxamic acids under Mitsunobu conditions. IR, NMR, and MS spectroscopies characterized the synthesized compounds. The final products were screened for their antifungal activity against five Candida spp., using microdilution assays and cytotoxicity against peripheral blood mononuclear cells by the MTT method.
Results: The products were obtained in good yields and the results showed that most of the synthesized compounds were better antifungal agents than eugenol against the Candida species evaluated and that the derivative IVd (IC50 53 μmol L-1) showed activity comparable to fluconazole against C. glabrata. Moreover, IVd showed the best selectivity profile among the synthesized new compounds.
Conclusion: A new 1,2-benzisoxazolin-3-one (IVd) was obtained as a promising candidate for the development of new antifungal agents based on a new chemical scaffold.
Export Options
About this article
Cite this article as:
Fregnan M. Antonio , Júnior A. Fernandes Antonio , Alvarenga J. Dalila , Oliver C. Josidel , Silva C. Naiara , Coelho F.L. Luiz , Dias L. Tranches Amanda , Dias F. Danielle, de Souza B. Thiago and Carvalho T. Diogo*, A New 1,2-Benzisoxazolin-3-one Synthetized from Eugenol Shows Anti- Candida Spp. Activity, Specially Against Opportunistic Candida Glabrata, Current Bioactive Compounds 2021; 17 (5) : e010621184056 . https://dx.doi.org/10.2174/1573407216999200723114241
DOI https://dx.doi.org/10.2174/1573407216999200723114241 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
Call for Papers in Thematic Issues
Antioxidants: Unveiling their Power in Health and Disease
Antioxidants have captured significant interest for decades due to their potential role in preventing chronic diseases. These molecules combat free radicals and unstable molecules that damage cells and contribute to the development of conditions like metabolic diseases, heart disease, cancer, and neurodegenerative diseases. This thematic issue will explore the cutting-edge ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Close Interplay of Nitro-Oxidative Stress, Advanced Glycation end Products and Inflammation in Inflammatory Bowel Diseases
Current Medicinal Chemistry The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders
Current Neuropharmacology Variability of Biological Activities of Limonoids Derived from Plant Sources
Mini-Reviews in Organic Chemistry Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease
Current Neuropharmacology NLRP3 Inhibitors as Potential Therapeutic Agents for Treatment of Inflammatory Bowel Disease
Current Pharmaceutical Design Fibrillar β-Amyloid Impairs the Late Phase of Long Term Potentiation
Current Alzheimer Research Disconnection of Language and Memory in Semantic Dementia: A Comparative and Theoretical Analysis
Current Alzheimer Research Transcranial Direct Current Stimulation for the Treatment of Refractory Symptoms of Schizophrenia. Current Evidence and Future Directions
Current Pharmaceutical Design Molecular Components of Wnt/β-catenin Pathway As Therapeutic Targets For Upper Gastrointestinal Cancers
Clinical Cancer Drugs Intramolecular Immunological Signal Hypothesis Revived - Structural Background of Signalling Revealed by Using Congo Red as a Specific Tool
Mini-Reviews in Medicinal Chemistry Targeting IGF-I, IGFBPs and IGF-I Receptor System in Cancer: The Current and Future in Breast Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Novel Directions in Antipsychotic Target Identification using Gene Arrays
Current Drug Targets - CNS & Neurological Disorders Levofloxacin-Induced Delirium in a Patient Suffering from Schizoaffective Disorder and Multiple Sclerosis
Current Drug Safety [35S]GTPγS Autoradiography: A Powerful Functional Approach with Expanding Potential for Neuropharmacological Studies on Receptors Coupled to Gi Family of G Proteins
Current Neuropharmacology Revisiting the Medical Management of Parkinson’s Disease: Levodopa versus Dopamine Agonist
Current Neuropharmacology Transcranial Direct Current Stimulation for Treatment of Auditory Hallucination: A Systematic Review of Clinical Efficacy
Current Psychiatry Reviews Molecular Iodine in the Synthesis of Chromone-type Compounds
Current Organic Synthesis Basic and Clinical Aspects of Gene Therapy for Retinopathy Induced by Diabetes
Current Gene Therapy Science and Technological Understanding of Nano-ionic Resistive Memories (RRAM)
Nanoscience & Nanotechnology-Asia HumDLoc: Human Protein Subcellular Localization Prediction Using Deep Neural Network
Current Genomics